Ifenprodil for the treatment of methamphetamine use disorder: An exploratory, randomized, double‐blind, placebo‐controlled trial

• Main Authors: Hiroko Kotajima‐Murakami (Author), Ayumi Takano (Author), Shinya Hirakawa (Author), Yasukazu Ogai (Author), Daisuke Funada (Author), Yuko Tanibuchi (Author), Eriko Ban (Author), Minako Kikuchi (Author), Hisateru Tachimori (Author), Kazushi Maruo (Author), Takahiro Kawashima (Author), Yui Tomo (Author), Tsuyoshi Sasaki (Author), Hideki Oi (Author), Toshihiko Matsumoto (Author), Kazutaka Ikeda (Author)
• Format: Book
• Published: Wiley, 2022-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Aim No effective pharmacological interventions have been developed for patients with methamphetamine use disorder. Ifenprodil is a blocker of G protein‐activated inwardly rectifying potassium channels, which play a key role in the mechanism of action of addictive substances. We conducted a...